Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Land & Improvements: 2013-2014

Historic Land & Improvements for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Dec 2014 value amounting to $7.0 million.

  • Amphastar Pharmaceuticals' Land & Improvements fell 3.62% to $6.9 million in Q2 2015 from the same period last year, while for Jun 2015 it was $6.9 million, marking a year-over-year decrease of 3.62%. This contributed to the annual value of $7.0 million for FY2014, which is 20.93% up from last year.
  • According to the latest figures from FY2014, Amphastar Pharmaceuticals' Land & Improvements is $7.0 million, which was up 20.93% from $5.8 million recorded in FY2013.
  • In the past 5 years, Amphastar Pharmaceuticals' Land & Improvements registered a high of $7.0 million during FY2014, and its lowest value of $5.8 million during FY2013.
  • Moreover, its 2-year median value for Land & Improvements was $6.4 million (2013), whereas its average is $6.4 million.
  • Data for Amphastar Pharmaceuticals' Land & Improvements shows a peak YoY increased of 20.93% (in 2014) over the last 5 years.
  • Yearly analysis of 2 years shows Amphastar Pharmaceuticals' Land & Improvements stood at $5.8 million in 2013, then climbed by 20.93% to $7.0 million in 2014.